International Journal of Diabetes & Metabolic Disorders(IJDMD)
ISSN: 2475-5451 | DOI: 10.33140/IJDMD
Impact Factor: 1.23
Alejandro Hernandez-Patricio
Laboratory of Experimental Metabolism and Clinical Research, Mexico
Publications
-
Research Article
Plasma Chemerin may predict Type-2 Diabetes Remission after Bariatric Surgery
Author(s): Angel Alfonso Garduno-Perez, Silvia Garcia3, Carlos Ramiro Zamora-Aleman, Alejandro Hernandez-Patricio, Eduardo Vera-Gomez, Andrea Ramirez-Coyotecatl, Dulce Cecilia Vazquez-Ramos, Karen De La Vega- Moreno, Gustavo De La Pena-Sosa, Jesus Montoya-Ramirez and Juan Antonio Suarez-Cuenca*
Bariatric surgery is an effective treatment for patients with severe obesity and type 2 diabetes mellitus (T2DM), leading to significant metabolic improvement and diabetes remission in a substantial proportion of cases. However, remission is not universal, and biological factors influencing postoperative metabolic response remain incompletely characterized. Adipokines such as chemerin and visfatin have been implicated in insulin resistance and adipose tissue inflammation and may contribute to heterogeneous outcomes after surgery. Aim: To evaluate metabolic changes associated with T2DM remission after bariatric surgery and to assess the relationship between preoperative circulating adipokines and diabetes remission. Methods: Prospective observational cohort study of 30 adults with T2DM and severe obesity undergoing bariatric surgery.. Read More»